Business Wire

1. Enhanced Genomics And The ALBORADA Drug Discovery Institute Partner To Accelerate Alzheimer's Drug Discovery 6/24/2025

   Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.

2. Axcelead DDP And Superluminal Announce The Intent To Collaborate On Drug Discovery Targeting Specific Molecular Mechanisms, Continuing A Productive Relationship 6/23/2025

   Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) and Superluminal Medicines, Inc. (Superluminal) announced the intention to collaborate on drug discovery targeting specific molecular mechanisms associated with challenging biological targets.

3. Archeus Technologies Receives FDA Clearance Of Investigational New Drug Application For ART-101 In Development For The Treatment Of Prostate Cancer 6/20/2025

   Archeus Technologies, a company developing radiopharmaceutical therapies for the treatment of patients with cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for ART-101, a novel receptor-based targeting small molecule that Archeus has developed for the imaging and treatment of prostate cancer.

4. Circle Pharma Receives FDA Orphan Drug Designation For CID-078 For The Treatment Of Small Cell Lung Cancer 6/16/2025

   Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to CID-078 for the treatment of small cell lung cancer (SCLC).

5. Fauna Bio Launches Fauna Brain AI Platform To Accelerate Drug Discovery Inspired By Nature's Most Resilient Species 6/16/2025

   Fauna Bio, a biotechnology company harnessing animal genomics to improve human health, today announced the launch of Fauna Brain, a proprietary AI platform designed to accelerate target discovery and streamline early-stage R&D.

6. China's Center For Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany's Application For Marketing Authorization Of Pimicotinib For Treatment Of Tenosynovial Giant Cell Tumor 6/10/2025

   Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) officially accepted the company’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with tenosynovial giant cell tumors (TGCT) requiring systemic treatment.

7. Emulate Launches AVA Emulation System To Accelerate Drug Development With First-Of-Its-Kind High-Throughput Organ-Chip Platform 6/10/2025

   Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent Organ-Chip samples in a single run.

8. CN Bio Introduces Cross-Species DILI Services To Enhance In Vitro To In Vivo Extrapolation During Preclinical Drug Development 6/10/2025

   CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS).

9. IonQ Speeds Quantum-Accelerated Drug Development Application With AstraZeneca, AWS, And NVIDIA 6/9/2025

   IonQ, a leading commercial quantum computing and networking company, announced results of a collaborative research program between IonQ, AstraZeneca, Amazon Web Services (AWS), and NVIDIA to develop and demonstrate a quantum-accelerated computational chemistry workflow which has the potential to power world-changing innovation in healthcare, life sciences, chemistry, and more.

10. Mission Bio Unveils Industry-First Single-Cell Genotype And Targeted Gene Expression Solution Aimed At Derisking Cancer Drug Clinical Development 6/5/2025

    Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the capabilities of its Tapestri Platform to become the only commercial solution that delivers simultaneous genotype and targeted gene expression profiling from over 10,000 single cells.